Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emisphere Technologies, a biopharmaceutical company, has appointed Kenneth Moch to its board of directors. Mr Moch will also serve on the Emisphere audit committee. He will fill the vacancy created by the death of Howard Pack, with a term that will continue until the company's 2010 annual meeting.
Subscribe to our email newsletter
Mr Moch is the founder and president of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies. He is a former managing director of ThinkEquity Partners, an investment bank focusing on high-growth companies, and former chairman, president and CEO of Alteon, a biotech company specializing in small molecule therapeutics for cardiovascular aging and diabetic complications.
Mr Moch holds a degree in biochemistry from Princeton University and received his MBA from the Stanford Graduate School of Business.
Michael Novinski, president and CEO of Emisphere, said: “Ken Moch has an impressive record advising the management and governing boards of biotechnology companies. His past experiences will provide leadership and benefit to Emisphere.”